CVS GROUP PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,158 GBX | +3.58% |
|
+7.62% | -31.19% |
| May. 23 | CVS Group says will back investigation by UK CMA into pet market | AN |
| May. 23 | CVS Group Signals Cooperation for UK Watchdog's Investigation into Veterinary Sector | MT |
| Sales 2024 * | 671M 855M | Sales 2025 * | 719M 916M | Capitalization | 831M 1.06B |
|---|---|---|---|---|---|
| Net income 2024 * | 43M 54.79M | Net income 2025 * | 52M 66.25M | EV / Sales 2024 * | 1.56 x |
| Net Debt 2024 * | 219M 279M | Net Debt 2025 * | 174M 222M | EV / Sales 2025 * | 1.4 x |
| P/E ratio 2024 * |
20
x | P/E ratio 2025 * |
15.9
x | Employees | 9,100 |
| Yield 2024 * |
0.68% | Yield 2025 * |
0.73% | Free-Float | 98.44% |
More Fundamentals
* Assessed data
More news
Latest transcript on CVS Group plc
More recommendations
More news
| 1 day | +3.58% | ||
| 1 week | +7.62% | ||
| 1 month | +18.28% | ||
| 3 months | -21.28% | ||
| 6 months | -22.28% | ||
| Current year | -31.19% |
1 week
1 054.00
1 164.48
1 month
931.001 164.48
Current year
902.411 739.00
1 year
902.412 226.00
3 years
902.412 835.00
5 years
610.002 835.00
10 years
299.752 835.00
| Managers | Title | Age | Since |
|---|---|---|---|
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
Robin Alfonso
DFI | Director of Finance/CFO | 45 | 19-11-05 |
Richard Killen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Deborah Kemp
BRD | Director/Board Member | 62 | 18-01-01 |
David Wilton
CHM | Chairman | 61 | 21-09-23 |
Richard Fairman
CEO | Chief Executive Officer | 57 | 18-07-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.84% | 1 M€ | -.--% | ||
| 0.04% | 746 M€ | -.--% | - | |
| 0.01% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 1,158 | +3.58% | 970,734 |
| 24-05-30 | 1,118 | +4.29% | 198,753 |
| 24-05-29 | 1,072 | +0.56% | 526,969 |
| 24-05-28 | 1,066 | -0.93% | 500,108 |
| 24-05-24 | 1,076 | +1.32% | 280,664 |
Delayed Quote London S.E., May 31, 2024 at 11:35 am EDT
More quotes
CVS Group plc (CVS) is a United Kingdom company that is engaged in providing veterinary services. The Company operates veterinary practices, veterinary diagnostic businesses, pet crematoria and an online retail business. The Companyâs segments include Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The Veterinary Practices division comprises 500 veterinary practices across three markets, including eight specialist referral hospitals and 37 out-of-hours sites, as well as its buying groups, Vet Direct and MiPet insurance. The Laboratories division provides diagnostic services and in-practice laboratory analyzers to CVS practices and third-party owned veterinary surgeries. The Crematoria division provides pet cremation and clinical waste disposal for CVS and third-party practices. The Online Retail Business includes Animed Direct, which is an online store selling medicines, pet food and other animal-related products.
Calendar
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
11.58
GBP
Average target price
16.51
GBP
Spread / Average Target
+42.58%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -31.19% | 1.06B | |
| -16.73% | 163M |
- Stock Market
- Equities
- CVSG Stock
